INDV ▾TradingViewOVTLYR consoleNews (1w)Earnings search — Indivior PLC

Healthcare · ETF XLV · as of 2026-09-18

Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ
INDV
Indivior PLC NMS
Healthcare · Pharmaceuticals

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Market cap
4.6B
P/E (TTM)
12.5
EPS (TTM)
2.79
Employees
838
IPO
2014-12-24
Website
indivior.com

Price & today

$34.88 ATR(14) 1.06 (3.03%)
Stock today-2.27%
Sector ETF today-0.25%
Residual (stock-specific)-2.02%

Sector correlation

20-day correlation with XLV0.21
60-day correlation with XLV0.26
Status normal

Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.

Technicals

10 EMA$34.87
20 EMA$35.41
50 EMA$36.71
EMA stackBEARISH
RSI(14)42.0
52-week high distance-18.52%
52-week low distance+59.78%

Signals

Market F&G46.9
Bull%12.2%
OVTLYR status —
Sector rank—
Next earnings 2026-10-28 (TNS, 39d)
TradingView OVTLYR console More news (Google) Sector dashboard (XLV)

MarketSmith metrics - our compute

RS Rating
26.0
ADR%
2.7
RMV (tight)
100.0
Ext (ATR>20EMA)
-0.5
Rel Vol
217.0%
U/D 50d
0.53
U/D 25d
0.49
Accum/Dist 25d
3 / 5
EPS YoY
+125.0%
LoD dist
27.0
Off 52w High
18.5%
Above 52w Low
57.0%
1W / 1M
+1.1 / -10.7
Avg $Vol 50d
80.5M
Mkt Cap (B)
4.1
Trend 8/8
no
Leads Group
no
Sector XLV
+1.8% 1W
Base len (VCP)
6wk (6/21)
Coil (base shape)
85TVPX
What do these abbreviations mean?
RS Rating
- IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
ADR%
- average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
RMV (tight)
- Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
Ext (ATR>20EMA)
- how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
Rel Vol
- latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
U/D 50d / 25d
- up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
Accum/Dist 25d
- heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
LoD dist
- close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
Off/Above 52w
- trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
Trend 8/8
- all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
Base len (VCP)
- weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.

Fundamentals & valuation - reference, not entry inputs

P/E (TTM)
12.5
Fwd P/E
7.6
PEG
-
Price/Book
-
Profit margin
26.8%
ROE
-
Debt/Equity
-
Rev growth
+13.6%
Analyst target
$49 (+40%)
Analyst rating
STRONG_BUY
Institutional %
114.6%
Insider %
2.0%
Float %
91.2%
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.

Company data - context read, not entry inputs

Industry rank
36 / 147
Industry
Pharmaceuticals
Float
107.8M
Float turnover 20d
2.0%
Avg $Vol 20d / 50d
75.1M / 80.5M
Days to cover
6.0
Short % float
11.3%
Institutional %
114.6%
Weinstein stage
1
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.

Quarterly EPS - earnings acceleration

A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.

QuarterEPS ($)%Chg YoYSales ($M)%Chg
Oct-24 0.54 +59% 307.0 -
Feb-25 0.32 -26% 299.0 -
Apr-25 0.41 +11% 266.0 -6%
Jul-25 0.51 +16% 302.0 +1%
Oct-25 0.72 +33% 314.0 +2%
Feb-26 0.82 +156% 358.0 +20%
Apr-26 0.96 +134% 317.0 +19%
Aug-26 1.15 +125% 343.0 +14%
† = SEC carries this same fiscal quarter under a second period-end with a materially different figure (hover for it) - a restatement, merger recast or successor-period split; %Chg is blanked when the two are more than 15% apart. It fires only when the two period-ends DISAGREE, so it is a floor, not a guarantee that the rest of the column shares one basis · ‡ = the revenue concept changed from the previous quarter WITH A FIGURE (hover for both) - a blank row in between is skipped, as the eye does - a step at that row is a change of basis, not necessarily of business · EPS = Yahoo eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).

Recent news - our DB (Finnhub + OVTLYR)